Portal de Periódicos da CAPES

Revisão Acesso aberto Produção Nacional Revisado por pares

BIBTEX RIS

Pilot study of mobile phone technology in allergic rhinitis in European countries: the MASK ‐rhinitis study

2017; Wiley; Volume: 72; Issue: 6 Linguagem: Inglês

10.1111/all.13125

1398-9995

Jean Bousquet, Davide Caimmi, Anna Bedbrook, M. Bewick, Peter W. Hellings, P. Devillier, S. Arnavielhe, Claus Bachert, Karl‐Christian Bergmann, Giorgio Walter Canonica, Niels H. Chavannes, Álvaro A. Cruz, Ronald Dahl, Pascal Demoly, Govert De Vries, E. Mathieu‐Dupas, Antjie Fink-Wagner, João Fonseca, N. Guldemond, Tari Haahtela, B. Hellqvist-Dahl, J. Just, Thomas Keil, Ludger Klimek, Marek L. Kowalski, M. Kuitunen, Piotr Kuna, Violeta Kvedarienė, D. Laune, Ana Margarida Pereira, Pedro Martins, Erik Melén, Mário Morais‐Almeida, Joaquim Mullol, Antonella Muraro, Ruth Murray, Luís Nogueira‐Silva, Nikolaos G. Papadopoulos, Giovanni Passalacqua, F. Portejoie, David Price, Dermot Ryan, Bolesław Samoliński, Aziz Sheikh, Valérie Siroux, O. Spranger, Ana Todo‐Bom, Peter Valentin Tomazic, A. Valero, Erkka Valovirta, Arūnas Valiulis, Olivier Vandenplas, Stan van der Meulen, M. van Eerd, Magnus Wickman, Torsten Zuberbier,

Food Allergy and Anaphylaxis Research

The use of Apps running on smartphones and tablets profoundly affects medicine. The MASK-rhinitis (MACVIA-ARIA Sentinel NetworK for allergic rhinitis) App (Allergy Diary) assesses allergic rhinitis symptoms, disease control and impact on patients' lives. It is freely available in 20 countries (iOS and Android platforms).To assess in a pilot study whether (i) Allergy Diary users were able to properly provide baseline characteristics (ii) simple phenotypic characteristics based upon data captured by the Allergy Diary could be identified and (iii) information gathered by this study could suggest novel research questions.The Allergy Diary users were classified into six groups according to the baseline data that they entered into the App: (i) asymptomatic; (ii) nasal symptoms excluding rhinorrhea; (iii) rhinorrhea; (iv) rhinorrhea plus 1-2 nasal/ocular symptoms; (v) rhinorrhea plus ≥3 nasal/ocular symptoms; and (vi) rhinorrhea plus all nasal/ocular symptoms.By 1 June 2016, 3260 users had registered with the Allergy Diary and 2710 had completed the baseline questionnaire. Troublesome symptoms were found mainly in the users with the most symptoms. Around 50% of users with troublesome rhinitis and/or ocular symptoms suffered work impairment. Sleep was impaired by troublesome symptoms and nasal obstruction.This is the first App (iOS and Android) to have tested for allergic rhinitis and conjunctivitis. A simple questionnaire administered by cell phones enables the identification of phenotypic differences between a priori defined rhinitis groups. The results suggest novel concepts and research questions in allergic rhinitis that may not be identified using classical methods.